Systematic Cellular Disease Models Reveal Synergistic Interaction of Trisomy 21 and GATA1 Mutations in Hematopoietic Abnormalities-Reference-Cited by-同舟云学术

Systematic Cellular Disease Models Reveal Synergistic Interaction of Trisomy 21 and GATA1 Mutations in Hematopoietic Abnormalities

Published:2016-05 Issue:6 Volume:15 Page:1228-1241
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Banno Kimihiko,Omori Sayaka,Hirata Katsuya,Nawa Nobutoshi,Nakagawa Natsuki,Nishimura Ken,Ohtaka Manami,Nakanishi Mahito,Sakuma Tetsushi,Yamamoto Takashi,Toki Tsutomu,Ito Etsuro,Yamamoto Toshiyuki,Kokubu Chikara,Takeda Junji,Taniguchi Hidetoshi,Arahori Hitomi,Wada Kazuko,Kitabatake Yasuji,Ozono Keiichi

Funder

Japan Science and Technology Agency

Ministry of Education, Culture, Sports, Science and Technology, Japan

JSPS

Japan Agency for Medical Research and Development (AMED)

Japan Foundation for Pediatric Research

Takeda Science Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference38 articles.

1. Changes in megakaryocytes in cases of thrombocytopenia: bone marrow aspiration and biopsy analysis;Bhasin;J. Clin. Diagn. Res.,2013

2. Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus;Byrska-Bishop;J. Clin. Invest.,2015

3. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter;Chen;Nature,2009

4. Hematopoietic disorders in Down syndrome;Choi;Int. J. Clin. Exp. Pathol.,2008

5. Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures;Choi;Cell Rep.,2012

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosomal and cellular therapeutic approaches for Down syndrome: A research update;Biochemical and Biophysical Research Communications;2024-11

2. Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer;International Journal of Molecular Sciences;2024-06-21

3. Landscape of driver mutations and their clinical effects on Down syndrome–related myeloid neoplasms;Blood;2024-06-20

4. Interactions among insulin resistance, epigenetics, and donor sex in gene expression regulation of iPSC-derived myoblasts;Journal of Clinical Investigation;2024-01-16

5. Down syndrome-associated leukaemias: current evidence and challenges;Therapeutic Advances in Hematology;2024-01